Diffuse large B-cell lymphoma relapse presenting as extensive neurolymphomatosis.
Pankaj NepalPrem P BatchalaPatrice K RehmCamilo E FadulPublished in: The neuroradiology journal (2020)
A 56-year-old woman with a history of diffuse large B-cell non-Hodgkin lymphoma (DLBCL-NHL) in remission for two years presented with weight loss and multifocal sensory/motor symptoms. Magnetic resonance imaging (MRI) of the neuraxis and whole-body FDG PET/CT led to a diagnosis of secondary neurolymphomatosis (NL). MRI demonstrated extensive thickening and enhancement of multiple cranial nerves and peripheral nerve plexuses with corresponding elevated metabolism on FDG PET/CT. Treatment with chemotherapy resulted in complete response on FDG PET/CT and subsequently she underwent autologous stem cell transplantation. NL is a rare manifestation of lymphoma affecting the peripheral nervous system. Nonspecific neuropathic symptoms make clinical diagnosis difficult. Though nerve biopsy is considered the gold standard, MRI and FDG PET/CT are accepted alternatives for making the diagnosis. We review imaging findings in NL, describe the differential diagnosis, and discuss the limitations of the imaging modalities.
Keyphrases
- diffuse large b cell lymphoma
- magnetic resonance imaging
- stem cell transplantation
- contrast enhanced
- peripheral nerve
- epstein barr virus
- weight loss
- diffusion weighted imaging
- high resolution
- computed tomography
- high dose
- bariatric surgery
- magnetic resonance
- sleep quality
- low grade
- stem cells
- roux en y gastric bypass
- chemotherapy induced
- mesenchymal stem cells
- body mass index
- low dose
- mass spectrometry
- replacement therapy
- depressive symptoms
- fine needle aspiration
- high grade
- ultrasound guided
- weight gain
- obese patients